2019
DOI: 10.1093/eurheartj/ehz745.0639
|View full text |Cite
|
Sign up to set email alerts
|

P3794MOODS: a novel risk score to identify patients with atrial fibrillation and sleep apnoea

Abstract: Background Sleep-disordered breathing (SDB) is an important risk factor for developing atrial fibrillation (AF), and treatment of concomitant SDB can improve AF rhythm outcomes. Diagnosis of SDB requires sleep studies which can pose a significant time and resource burden. We sought to develop a prediction score based on clinical characteristics that can help identify AF patients who require further assessment for SDB. Methods … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
1
0
4

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 0 publications
0
1
0
4
Order By: Relevance
“…OSA screening questionnaires and scales are sometimes used in the general population or specific patient populations (e.g., surgical patients), but performance is insufficient to screen for OSA in AF patients. ( 8 10 ) Currently, polysomnography (PSG) is the accepted gold standard for diagnosing OSA. Additionally, OSA diagnosis by PSG is mandatory before starting CPAP therapy in several countries ( 11 ).…”
Section: Introductionmentioning
confidence: 99%
“…OSA screening questionnaires and scales are sometimes used in the general population or specific patient populations (e.g., surgical patients), but performance is insufficient to screen for OSA in AF patients. ( 8 10 ) Currently, polysomnography (PSG) is the accepted gold standard for diagnosing OSA. Additionally, OSA diagnosis by PSG is mandatory before starting CPAP therapy in several countries ( 11 ).…”
Section: Introductionmentioning
confidence: 99%
“…En el estudio original de validación de la escala MOODS, realizada sobre 442 pacientes con fibrilación auricular, la prevalencia de AOS moderada-severa fue de 33.7% 26 . En el presente estudio los hallazgos son consistentes con una prevalencia de AOS moderada a severa del 54.8%, mayor que lo comunicado en otras experiencias europeas y norteamericanas 25,26,29 . Es digno de mencionar que un 10.9% de los pacientes no recibían un tratamiento anticoagulante, a pesar de un elevado riesgo de cardioembolia.…”
Section: Discussionunclassified
“…La puntuación MOODS obtuvo su mejor relación S/Sp con tres componentes, a diferencia de la comunicación inicial de Kadhim y cols. 25 en que requirió de cuatro componentes. La identificación clínica de ronquidos demostró ser un buen predictor, aun después de ajustar para múltiples otras variables.…”
Section: Discussionunclassified
See 2 more Smart Citations